STI
35
14
SRE
47
7
GT
47
4
IFF
47
3
HAL
34
7
FRT
39
3
WMT
68
2
FTI
63
2
CRM
67
2
GWW
51
3
APA
35
3
ISRG
70
4
KMB
31
3
ADT
27
2
CNP
54
4
WHR
64
2
ETR
65
4
CMA
46
3
SLG
38
3
EA
44
3
STI
35
14
SRE
47
7
GT
47
4
IFF
47
3
HAL
34
7
FRT
39
3
WMT
68
2
FTI
63
2
CRM
67
2
GWW
51
3
APA
35
3
ISRG
70
4
KMB
31
3
ADT
27
2
CNP
54
4
WHR
64
2
ETR
65
4
CMA
46
3
SLG
38
3
EA
44
3
Financhill
Back

Trevi Therapeutics 10K Form

Sell
49

TRVI
Trevi Therapeutics

Last Price:
$3.99
Seasonality Move:
52.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRVI News And Ratings

See the #1 stock for the next 7 days that we like better than TRVI

TRVI Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-9.6M
Price / Cash Flow: 0
Annual Sales: $0.78
Price / Book: 5.21

Profitability

EPS (TTM): -0.44000
Net Income (TTM): $-44.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Trevi Therapeutics Earnings Forecast

Key Trevi Therapeutics Financial Ratios

  • The Interest Expense is -1.35% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 5 years.

Trevi Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TRVI
CUSIP: 89532M
Website: trevitherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRVI Technical Analysis vs Fundamental Analysis

Sell
49
Trevi Therapeutics (TRVI) is a Sell

Is Trevi Therapeutics a Buy or a Sell?